DNA3'pp5'G de-capping activity of aprataxin: Effect of cap nucleoside analogs and structural basis for guanosine recognition Journal Article


Authors: Chauleau, M.; Jacewicz, A.; Shuman, S.
Article Title: DNA3'pp5'G de-capping activity of aprataxin: Effect of cap nucleoside analogs and structural basis for guanosine recognition
Abstract: DNA3'pp5'G caps synthesized by the 3'-PO4/5'-OH ligase RtcB have a strong impact on enzymatic reactions at DNA 3'-OH ends. Aprataxin, an enzyme that repairs A5'pp5'DNA ends formed during abortive ligation by classic 3'-OH/5'-PO4 ligases, is also a DNA 3' de-capping enzyme, converting DNAppG to DNA(3')p and GMP. By taking advantage of RtcB's ability to utilize certain GTP analogs to synthesize DNAppN caps, we show that aprataxin hydrolyzes inosine and 6-O-methylguanosine caps, but is not adept at removing a deoxyguanosine cap. We report a 1.5 angstrom crystal structure of aprataxin in a complex with GMP, which reveals that: (i) GMP binds at the same position and in the same anti nucleoside conformation as AMP; and (ii) aprataxin makes more extensive nucleobase contacts with guanine than with adenine, via a hydrogen bonding network to the guanine O6, N1, N2 base edge. Alanine mutations of catalytic residues His147 and His149 abolish DNAppG de-capping activity, suggesting that the 3' de-guanylylation and 5' de-adenylylation reactions follow the same pathway of nucleotidyl transfer through a covalent aprataxin-(His147)-NMP intermediate. Alanine mutation of Asp63, which coordinates the guanosine ribose hydroxyls, impairs DNAppG decapping. © The Author(s) 2015.
Journal Title: Nucleic Acids Research
Volume: 43
Issue: 12
ISSN: 0305-1048
Publisher: Oxford University Press  
Date Published: 2015-07-13
Start Page: 6075
End Page: 6083
Language: English
DOI: 10.1093/nar/gkv501
PROVIDER: scopus
PMCID: PMC4499129
PUBMED: 26007660
DOI/URL:
Notes: Export Date: 2 October 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stewart H Shuman
    546 Shuman